Success Metrics

Clinical Success Rate
96.3%

Based on 259 completed trials

Completion Rate
96%(259/269)
Active Trials
13(4%)
Results Posted
25%(66 trials)
Terminated
10(3%)

Phase Distribution

Ph not_applicable
12
4%
Ph phase_4
17
6%
Ph phase_1
215
71%
Ph phase_3
26
9%
Ph phase_2
30
10%

Phase Distribution

215

Early Stage

30

Mid Stage

43

Late Stage

Phase Distribution300 total trials
Phase 1Safety & dosage
215(71.7%)
Phase 2Efficacy & side effects
30(10.0%)
Phase 3Large-scale testing
26(8.7%)
Phase 4Post-market surveillance
17(5.7%)
N/ANon-phased studies
12(4.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.5%

259 of 274 finished

Non-Completion Rate

5.5%

15 ended early

Currently Active

13

trials recruiting

Total Trials

303

all time

Status Distribution
Active(18)
Completed(259)
Terminated(15)
Other(11)

Detailed Status

Completed259
Terminated10
unknown10
Recruiting8
Withdrawn5
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
303
Active
13
Success Rate
96.3%
Most Advanced
Phase 4

Trials by Phase

Phase 1215 (71.7%)
Phase 230 (10.0%)
Phase 326 (8.7%)
Phase 417 (5.7%)
N/A12 (4.0%)

Trials by Status

suspended10%
terminated103%
withdrawn52%
unknown103%
completed25985%
active_not_recruiting52%
not_yet_recruiting52%
recruiting83%

Recent Activity

Clinical Trials (303)

Showing 20 of 303 trialsScroll for more
NCT06253715Phase 3

Shortened Regimen for Drug-susceptible TB in Children

Recruiting
NCT07485010Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not Yet Recruiting
NCT07422298Phase 1

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Recruiting
NCT06200467Phase 1

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

Completed
NCT07305831Phase 1

A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)

Active Not Recruiting
NCT07063238Phase 1

A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

Completed
NCT07229157Phase 1

Effect of Maridebart Cafraglutide on the Heart's Electrical Activity

Active Not Recruiting
NCT06441006Phase 2

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Recruiting
NCT07272629Phase 1

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

Recruiting
NCT07023029Phase 1

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Completed
NCT00042289

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Completed
NCT06107036Phase 1

A Study in Healthy People to Test Whether Different Doses of BI 1015550 Have Potential to Induce Heart Rhythm Abnormalities

Completed
NCT01298336Phase 3

Treatment of Mycobacterium Xenopi Pulmonary Infection

Completed
NCT06846866Phase 1

A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy Participants

Completed
NCT07214935Phase 1

A TQT Study of Effect of M2951 on Cardiac Repolarization

Completed
NCT06411860Phase 1

A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants

Completed
NCT05807399Phase 2

PanACEA - STEP2C -01

Recruiting
NCT06746402Phase 1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986278 on Cardiac Repolarization in Healthy Participants

Completed
NCT03244072Phase 2

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Not Yet Recruiting
NCT05766267Phase 2

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
303